BI
Biora Therapeutics, Inc.
BIORQ · OTC
$0.22 +0.00% (+$0.00)
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/FCF N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 5.31x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BIORQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Aditya Mohanty
Employees
58
Headquarters
San Diego
Nadcházející události
12 LIS
Earnings
Upcoming earnings report